# ClinicalTrials.gov record NCT00551343

> PeptideScanner retained ClinicalTrials.gov record NCT00551343 at 2026-07-30T20:25:27.243Z. Its registry update date was 2020-07-07, and PeptideScanner's reviewed identity mapping was exenatide.

- Evidence object: `story:clinicaltrials-gov-nct00551343-exenatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2020-07-07
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00551343-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00551343-exenatide-v1.json
- Content SHA-256: `07573209cd54e52a4eb8e7bafafa62315c4c3c155da98b10c1dce9b68cd61cd3`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00551343 ([`ctg-observation-nct00551343-2020-07-07-5b389c4986d0`](#source-ctg-observation-nct00551343-2020-07-07-5b389c4986d0))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00551343 at 2026-07-30T20:25:27.243Z. Its registry update date was 2020-07-07, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct00551343-2020-07-07-5b389c4986d0`](#source-ctg-observation-nct00551343-2020-07-07-5b389c4986d0))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00551343 at 2026-07-30T20:25:27.243Z. Its registry update date was 2020-07-07, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct00551343-2020-07-07-5b389c4986d0`](#source-ctg-observation-nct00551343-2020-07-07-5b389c4986d0))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00551343-2020-07-07-5b389c4986d0`](#source-ctg-observation-nct00551343-2020-07-07-5b389c4986d0))

## Sources

<a id="source-ctg-observation-nct00551343-2020-07-07-5b389c4986d0"></a>
- **ClinicalTrials.gov record NCT00551343 · retained source version 2020-07-07:5b389c4986d0439f18f19d19d9db24bc568552ae71dddc6ceae42e539ac9c0ca** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00551343) (`ctg-observation-nct00551343-2020-07-07-5b389c4986d0`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00551343." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00551343-exenatide-v1.json SHA-256: 07573209cd54e52a4eb8e7bafafa62315c4c3c155da98b10c1dce9b68cd61cd3.